Dentons | Czech Republic | 11 Jan 2024
Regarding medicinal products that have a maximum price or are reimbursed from public health insurance, marketing authorization holders (MAHs) will be…
Dentons | Czech Republic | 10 Jan 2024
Držitelé rozhodnutí o registraci (MAH) budou mít v případě léčiv, která mají stanovenou maximální cenu nebo úhradu z veřejného zdravotního pojištění…
Kinstellar | Czech Republic | 5 Jan 2024
An amendment to the Pharmaceuticals Act has been adopted by the Czech parliament and officially published…
Baker McKenzie | Czech Republic | 29 Nov 2023
Progress in legislative process and summary of key proposed changes under the draft amendment to the Act on Medicinal Products and the Act on Public…
Dentons | Czech Republic, European Union | 13 Nov 2023
We look at the most recent legislative developments affecting the amendments to the Medicines Act and Health Services Act. We also inform you about…
Dentons | Czech Republic, European Union | 12 Nov 2023
Vážení čtenáři, s radostí vám přinášíme nové vydání Life Science Legal Update, našeho pravidelného zpravodaje, jenž se věnuje klíčovým právním…
Panoramic
PRO
Editor:
Paul Hermant
Bird & Bird LLP
Panoramic guide (formerly Getting the Deal Through) enabling side-by-side comparison of local insights into transactional considerations (including structures, timelines, representations and warranties, due diligence, warranty and indemnity insurance, pre-closing conditions and covenants, and post-completion undertakings); regulation (including restrictions on owners, directors, overseas operations and cross-border acquirers; competition and merger control, and regulation and state and private healthcare combinations); financing and valuation; tax; public relations and policy considerations; and recent trends.